JCAP NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Jefferson Capital, Inc. Common Stock · Financial Services · Credit Services

Open interactive chart View report data
Latest close 20.11 USD
1.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 3.1% above the Trend Line and sits at 61.2% of its 52-week range. The latest completed week returned 1.5%, after a 6.9% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 11d.

Setup score 46 out of 100
Latest Close 20.11 USD 31 Jul 2026
1W Return 1.5% latest completed week
4W Return 6.9% short-term follow-through
12W Return 2.2% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.5% Latest completed week; four-week move 6.9%. Indicator stack 10/72 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 56 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 3.1% above the Trend Line and sits at 61.2% of its 52-week range. The latest completed week returned 1.5%, after a 6.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2212-week average 0.23

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.22Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 6.9% over four weeks, 2.2% over 12 weeks, and 29.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.5%
4W6.9%
12W2.2%
26W-3.4%
52W29.9%
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.42Latest activity-pressure read.
Pressure change176.6%Four-week change in activity pressure.
Leadership-4.71Latest relative-leadership reading.
RS change66.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength96/100Blend of value, momentum, and quality. Underlying universe rank 5; rank 1 is best.
Value86/100Relative valuation strength. Underlying universe rank 15; rank 1 is best.
Quality95/100Profitability and accounting quality. Underlying universe rank 6; rank 1 is best.
Momentum71/100Medium-term price momentum. Underlying universe rank 30; rank 1 is best.
Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework69/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
7.6x
Price divided by trailing earnings.
Price / sales
1.9x
Market value relative to trailing revenue.
EV / EBITDA
10.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
66.8%
Gross profit retained from each unit of revenue.
Operating margin
40.7%
Operating profit retained from revenue.
Free-cash-flow margin
40.0%
Free cash flow generated from revenue.
Return on invested capital
11.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
30.0%
Latest one-year revenue growth.
EPS growth
31.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
33.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.8%
Cash dividends relative to market value.
Buyback yield
-0.8%
Net share repurchases relative to market value.
Shareholder yield
4.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
5.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

14 positive · 42 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.3%Distance below the 52-week high.
13-week volatility5.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+10.3%Week of 26 Jun.
Worst week-10.5%Week of 15 May.
Latest week+1.5%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains9
Flat weeks0
Modest losses9
Sharp losses4
Recent vol5.0%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.22; No reversal markers Factors87/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 77; Small Cap Core rank 18 SVQF69/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 223.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

Jefferson Capital Inc (JCAP) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders50/100

No recent insider transaction evidence is stored.

 Earnings11d

Next report is scheduled for 13 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.11 USD1.5%19.51 USD18.96 USD0.42-4.711.5MOff
24 Jul 202619.82 USD1.4%19.56 USD18.94 USD0.18-5.501.4MOff
17 Jul 202619.54 USD3.7%19.65 USD18.93 USD0.07-8.302.1MOff
10 Jul 202618.85 USD0.2%19.73 USD18.92 USD-0.25-15.241.0MOff
3 Jul 202618.82 USD-1.6%19.81 USD18.92 USD-0.54-14.001.2MOff
26 Jun 202619.13 USD10.3%19.84 USD18.92 USD-0.78-12.083.2MOff
19 Jun 202617.34 USD6.0%19.89 USD18.92 USD-1.11-24.181.5MOff
12 Jun 202616.36 USD0.7%19.98 USD18.95 USD-1.22-931.0KOff
5 Jun 202616.24 USD-4.4%20.15 USD19.00 USD-1.23-1.3MOff
29 May 202616.99 USD-0.4%20.23 USD19.06 USD-1.06-928.7KOff
22 May 202617.05 USD-3.2%20.27 USD19.10 USD-0.82-1.5MOff
15 May 202617.63 USD-10.5%20.31 USD19.14 USD-0.66-977.1KOff
8 May 202619.69 USD-4.4%20.30 USD19.18 USD-0.43-1.0MOff
1 May 202620.58 USD2.1%20.20 USD19.16 USD-0.50-919.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.